Neurovalens’ Modius Sleep: A Breakthrough Drug-Free Solution for Chronic Insomnia

Patient Stories: How MedTech Innovator alumni are transforming lives

At MedTech Innovator we empower healthtech companies to bring groundbreaking solutions to patients in need. Our Patient Stories series highlights the real-world clinical impact of the companies we support—showcasing how their technologies are transforming patient care, improving outcomes, and advancing healthcare. Neurovalens was a participant in the 2022 MedTech Innovator cohort.

Neurovalens is advancing the treatment of chronic insomnia with Modius Sleep, a non-invasive, drug-free, physician-prescribed medical device designed to improve sleep by targeting the brain’s natural sleep mechanisms. For adults aged 22 and over who struggle with long-term insomnia, Modius Sleep offers a science-backed alternative to medications and traditional sleep therapies.

A New Approach to Sleep Improvement

Modius Sleep is worn as a lightweight headset for 30 minutes each evening. During use, it delivers gentle electrical vestibular nerve stimulation, known as VeNS. This non-invasive therapeutic method sends a safe electrical pulse into the vestibular nerve through two self-adhesive electrode pads placed on the skin behind each ear. By stimulating this nerve, the device influences key areas of the hypothalamus and brainstem that regulate circadian rhythm and sleep patterns, helping the brain return to healthier and more consistent sleep behavior. 

Designed for convenience, Modius Sleep fits seamlessly into a normal evening routine. Patients use the device at home before bed and can comfortably read, watch a movie, or browse the internet while wearing it. Remaining seated is recommended, but otherwise the device requires little change to daily habits.

Proven, Science-Backed Technology

The technology behind Modius Sleep is supported by scientific research and clinical trials. In studies, 95 percent of participants experienced improved sleep within four weeks, although individual results may vary. In addition, Modius Sleep received FDA 510(k) clearance in 2023, confirming its status as a regulated medical device.

Jan’s Journey: From Decades of Insomnia to Restful Sleep

For Jan, chronic insomnia was not a short-term struggle but a lifelong burden. She has suffered from chronic sleep insomnia since the mid-1970s and has tried nearly every option available, including Ambien, Doxepin, sleep patches, gummies, and sleep therapy, all without lasting improvement.

Jan received her Modius Sleep headset in late 2024. Within the first few nights of use, she began sleeping four to five hours per night. Over the following weeks, her sleep steadily improved to six to eight hours, then eight to nine hours, and eventually up to ten straight hours of sleep. 

“I’ve got to thank Neurovalens for this product, for bringing my life back to me, and I recommend this highly for anyone who has chronic sleep insomnia. There is hope.”

Redefining What’s Possible for Insomnia Patients

Jan’s experience highlights the potential of Modius Sleep to transform the lives of individuals who have struggled with chronic insomnia for years. By offering a non-invasive, FDA-cleared, drug-free solution grounded in neuroscience and clinical research, Neurovalens is redefining what effective sleep therapy can look like.

For patients who have exhausted traditional treatment options, Modius Sleep represents a new pathway, one that works with the brain to restore healthier sleep patterns and improve overall quality of life.

About Neurovalens

Neurovalens is a global health-tech company focused on developing non-invasive neurostimulation products to solve some of the world’s most significant health challenges. The company’s Modius technology is FDA-cleared, non-invasive, and influences the deep parts of the brain with a small and safe electrical pulse. The non-invasive approach removes the need for surgical implantation and allows much earlier intervention in the treatment pathway. Neurovalens is currently working to release several versions of the technology to treat various disorders. Modius Sleep is the first product to be released in October of 2024. The Neurovalens headquarters is in Belfast, United Kingdom. 

More information on how Modius Sleep works, including clinical papers and clinical trial details, can be found at neurovalens.com.